SCHEMBL3560550

SCHEMBL3560550

COc1ccc2[nH]c(SCc3ccc4oc(C(=O)O)cc4c3)nc2c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2E1 P05181 14/20 0.58
CYP2C8 P10632 14/20 0.58
CYP2D6 P10635 14/20 0.58
CYP2C9 P11712 14/20 0.58
CYP2B6 P20813 14/20 0.58
CYP2C19 P33261 14/20 0.58
CYP3A4 P08684 12/20 0.58
CYP1A2 P05177 12/20 0.58
NPC1 O15118 2/20 0.50
RAB9A P51151 2/20 0.50
SMN1; SMN2 Q16637 2/20 0.50
LMNA P02545 2/20 0.50
TP53 P04637 2/20 0.50
MEN1 O00255 1/20 0.50
NFKB1 P19838 1/20 0.50
NFKB2 Q00653 1/20 0.50
KMT2A Q03164 1/20 0.50
RELA Q04206 1/20 0.50
BRS3 P32247 1/20 0.49
HDAC1 Q13547 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1065533 0.84 HDAC1 (0.66) CYP2E1CYP2C8CYP2D6CYP2C9CYP2B6
SCHEMBL1065421 0.82 CYP2E1 (0.83) CYP2E1CYP2C8CYP2D6CYP2C9CYP2B6
SCHEMBL15693611 0.79 RAB9A (0.76) CYP2E1CYP2C8CYP2D6CYP2C9CYP2B6
SCHEMBL15693631 0.79 CYP2E1 (0.82) CYP2E1CYP2C8CYP2D6CYP2C9CYP2B6
SCHEMBL1063187 0.77 CYP2E1 (0.68) CYP2E1CYP2C8CYP2D6CYP2C9CYP2B6
SCHEMBL4650009 0.77 CYP2E1 (0.81) CYP2E1CYP2C8CYP2D6CYP2C9CYP2B6
SCHEMBL15693621 0.76 NPC1 (0.81) CYP2E1CYP2C8CYP2D6CYP2C9CYP2B6
SCHEMBL12195173 0.75 CYP2E1 (0.82) CYP2E1CYP2C8CYP2D6CYP2C9CYP2B6
SCHEMBL13381572 0.75 NPC1 (0.61) CYP2E1CYP2C8CYP2D6CYP2C9CYP2B6
SCHEMBL8347852 0.75 RAB9A (0.61) CYP2E1CYP2C8CYP2D6CYP2C9CYP2B6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7838520-B2 Inhibitors of histone deacetylase METHYLGENE, INC. (CA) 2010-11-23 US claimed
US-7838520-B2 Inhibitors of histone deacetylase METHYLGENE, INC. (CA) 2010-11-23 US disclosed
US-20060058298-A1 Inhibitors of histone deacetylase METHYLGENE, INC. 2006-03-16 US disclosed
US-20050288282-A1 Inhibitors of histone deacetylase METHYLGENE, INC. 2005-12-29 US disclosed
US-6897220-B2 Inhibitors of histone deacetylase METHYLGENE, INC. (CA) 2005-05-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288282-A1 Inhibitors of histone deacetylase HDAC1, HDAC5, HDAC3 CYP2E1 4369/4885CYP2C8 4554/4885CYP2D6 4762/4885
US-20060058298-A1 Inhibitors of histone deacetylase HDAC1, HDAC5, HDAC3 CYP2E1 4369/4885CYP2C8 4554/4885CYP2D6 4762/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.